MyFinsight
Home
Blog
About
Contact
Download
Download image
Net proceeds from
issuance of loan
$18,164,795
Proceeds from issuance of
common stock, net of...
$9,709,064
Proceeds from issuance of
warrants
$5,315,811
Proceeds from issuance of
common stock from...
$4,274,312
Proceeds from issuance of
pre-funded warrants
$1,038,094
Proceeds from exercise of
pre-funded warrants
$100
Net cash provided by
financing activities
$12,774,390
Canceled cashflow
$25,727,786
Net (decrease)
increase in cash and cash...
-$14,977,622
Canceled cashflow
$12,774,390
Stock-based compensation
expense
$4,106,606
Accounts payable
$1,889,580
Amortization of debt discount
$1,553,835
Loss on retirement of
debt
-$1,107,004
Issuance of shares in
consulting agreements
$298,501
Finance lease
amortization expense
$38,682
Depreciation expense
$21,836
Loan repayment
$19,000,000
Loan principal
payments
$6,666,667
Payments of finance lease
obligations
$61,119
Net cash used in
operating activities
-$27,752,012
Canceled cashflow
$9,016,044
Interest income
$1,217,241
Benefit for income taxes
-$1,169,820
Net loss
-$34,495,505
Canceled cashflow
$2,387,061
Accrued expenses
-$2,098,987
Prepaid expenses and
other current assets
$173,564
Total operating
expenses
$31,543,959
Interest expense
$5,338,607
Back
Back
Cash Flow
source: myfinsight.com
PDS Biotechnology Corp (PDSB)
PDS Biotechnology Corp (PDSB)